Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future

References

• Patterson SM, Cadogan CA, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;10:Cd008165.
   PubMed Web of Science ®Google Scholar
• NHS Scotland. Polypharmacy guidance. Mar 2015. Available from: http://www.sehd.scot.nhs.uk/publications/DC20150415polypharmacy.pdf.
   Google Scholar
• Hovstadius TS, Petterson G, Astrand B. Prevalence and therapeutic intensity of dispensed drug groups for individuals with multiple medications: a register-based study of 2.2 million individuals. JPHSR. 2010;1:145–155.
   Google Scholar
• Bushardt RL, Massey EB, Simpson TW, et al. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3(2):383–389.
   PubMed Web of Science ®Google Scholar
• Nobili A, Franchi C, Pasina L, et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf. 2011;20(5):488–496.
   PubMed Web of Science ®Google Scholar
• Jyrkka J, Vartiainen L, Hartikainen S, et al. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study. Eur J Clin Pharmacol. 2006;62(2):151–158.
   PubMed Web of Science ®Google Scholar
• Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–351.
   PubMedGoogle Scholar
• Matanovic SM, Vlahovic-Palcevski V. Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs. Eur J Clin Pharmacol. 2014;70(4):483–490.
   PubMed Web of Science ®Google Scholar
• Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11–23.
   PubMed Web of Science ®Google Scholar
• Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother. 2011;9(6):364–377.
   PubMed Web of Science ®Google Scholar
• Hamilton HJ, Gallagher PF, O’Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 2009;9:5.
   PubMedGoogle Scholar
• Ghibelli S, Marengoni A, Djade CD, et al. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck((R))). Drugs Aging. 2013;30(10):821–828.
   PubMed Web of Science ®Google Scholar
• Nobili A, Garattim S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorbidity. 2011;1:28–44.
   PubMedGoogle Scholar
• Richardson K, Bennett K, Kenny RA. Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults. Age Ageing. 2015;44(1):90–96.
   PubMed Web of Science ®Google Scholar
• Pasina L, Brucato AL, Falcone C, et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014;31(4):283–289.
   PubMed Web of Science ®Google Scholar
• Wallace J, Paauw DS. Appropriate prescribing and important drug interactions in older adults. Med Clin North Am. 2015;99(2):295–310.
   PubMed Web of Science ®Google Scholar
• Jäger C, Szecsenyi J, Steinhäuser J. Design and delivery of a tailored intervention to implement recommendations for multimorbid patients receiving polypharmacy into primary care practices. Biomed Res Int. 2015;1–9. Article ID 938069.
   Web of Science ®Google Scholar
• Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166(6):605–609.
   PubMedGoogle Scholar
• NHS Scotland. Polypharmacy guidance. Oct 2012. Available from: http://www.central.knowledge.scot.nhs.uk/upload/Polypharmacy%20full%20guidance%20v2.pdf.
   Google Scholar
• Wladysiuk M, Tabor A, Godman B. ‘HTA for Crisis’: sharing experiences during the 7th EBHC symposium. Expert Rev Pharmacoecon Outcomes Res. 2013;13(1):47–49.
   PubMed Web of Science ®Google Scholar
• Godman B, Paterson K, Malmstrom RE, et al. Improving the managed entry of new medicines: sharing experiences across Europe. Expert Rev Pharmacoecon Outcomes Res. 2012;12(4):439–441.
   PubMed Web of Science ®Google Scholar
• Patterson SM, Hughes C, Kerse N, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2012;5:Cd008165.
   PubMed Web of Science ®Google Scholar
• Ruggiero C, Dell’Aquila G, Gasperini B, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747–758.
   PubMed Web of Science ®Google Scholar
• Slabaugh SL, Maio V, Templin M, et al. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging. 2010;27(12):1019–1028.
   PubMed Web of Science ®Google Scholar
• Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract. 2007;24(1):14–19.
   PubMed Web of Science ®Google Scholar
• Jyrkka J, Enlund H, Korhonen MJ, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging. 2009;26(6):493–503.
   PubMed Web of Science ®Google Scholar
• Bjerrum L, Sogaard J, Hallas J, et al. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol. 1998;54(3):197–202.
   PubMed Web of Science ®Google Scholar
• Jyrkka J, Enlund H, Korhonen MJ, et al. Polypharmacy status as an indicator of mortality in an elderly population. Drugs Aging. 2009;26(12):1039–1048.
   PubMed Web of Science ®Google Scholar
• Kim HA, Shin JY, Kim MH, et al. Prevalence and predictors of polypharmacy among Korean elderly. Plos One. 2014;9(6):e98043.
   PubMed Web of Science ®Google Scholar
• Lewis T. Using the NO TEARS tool for medication review. BMJ (Clinical Research Ed). 2004;329(7463):434.
   PubMed Web of Science ®Google Scholar
• Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809–817.
   PubMed Web of Science ®Google Scholar
• Veehof L, Stewart R, Haaijer-Ruskamp F, et al. The development of polypharmacy. A longitudinal study. Fam Pract. 2000;17(3):261–267.
   PubMed Web of Science ®Google Scholar
• Holbeach E, Yates P. Prescribing in the elderly. Aust Fam Physician. 2010;39(10):728–733.
   PubMed Web of Science ®Google Scholar
• Franchi C, Tettamanti M, Pasina L, et al. Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000–2010. Eur J Clin Pharmacol. 2014;70(4):437–443.
   PubMed Web of Science ®Google Scholar
• Fadare JO, Agboola SM, Opeke OA, et al. Prescription pattern and prevalence of potentially inappropriate medications among elderly patients in a Nigerian rural tertiary hospital. Ther Clin Risk Manag. 2013;6:115–120.
   PubMed Web of Science ®Google Scholar
• Guthrie B, Treweek S, Petrie D, et al. Protocol for the Effective Feedback to Improve Primary Care Prescribing Safety (EFIPPS) study: a cluster randomised controlled trial using ePrescribing data. BMJ Open. 2012;2(6). pii: e002359. doi: 10.1136/bmjopen-2012-002359
   PubMed Web of Science ®Google Scholar
• Šter MP, Gorup C, Klančič D. Polypharmacy and inappropriate drug prescribing in elderly nursing home residents. Zdrav Vestn. 2009;78:231–240.
   Google Scholar
• Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–679.
   PubMed Web of Science ®Google Scholar
• Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–2724.
   PubMed Web of Science ®Google Scholar
• Kaplan W, Wirtz V, Mantel-Teeuwisse A, et al. Priority medicines for Europe and the World 2013 update report. 2013. Available from: http://www.who.int/medicines/areas/priority_medicines/MasterDocJune28_FINAL_Web.pdf?ua=1.
   Google Scholar
• Garattini S, Bertele V, Godman B, et al. Enhancing the rational use of new medicines across European health care systems. Eur J Clin Pharmacol. 2008;64(12):1137–1138.
   PubMed Web of Science ®Google Scholar
• Ogura S, Jakovljevic M. Health financing constrained by population aging – an opportunity to learn from Japanese experience. Ser J Exp Clin Res. 2014;15(4):175–181.
   Google Scholar
• Bagari Bizjak N, Fürst J, Kramberger B, et al. Kakovost predpisovanja v družinski medicini. Recept. 2011;9(1):93–95.
   Google Scholar
• Mrak J, Fürst J, Premuš M. Kakovostno predpisovanje zdravil – model pristopa k polifarmakoterapiji. n 2. Slovensko srečanje o klinični farmakologiji, VARNA UPORABA ZDRAVIL: Slovensko zdravniško društvo; 2014; str 131–135.
   Google Scholar
• Markovic-Pekovic V, Skrbic R, Godman B, et al. Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Rev Pharmacoecon Outcomes Res. 2012;12(5):661–671.
   PubMed Web of Science ®Google Scholar
• Petrusic T, Jakovljevic M. Budget impact of publicly reimbursed prescription medicines in the Republic of Srpska. Front Public Health. 2015;3:213.
   PubMed Web of Science ®Google Scholar
• Kennerfalk A, Ruigomez A, Wallander MA, et al. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother. 2002;36(5):797–803.
   PubMed Web of Science ®Google Scholar
• Chitnis A, Wang R, Sun SX, et al. Impact of initiation of asenapine on patterns of utilization and cost of healthcare resources associated with the treatment of bipolar I disorder. J Med Econ. 2015;18(11):863–870.
   Web of Science ®Google Scholar
• Rozenfeld S, Fonseca MJ, Acurcio FA. Drug utilization and polypharmacy among the elderly: a survey in Rio de Janeiro City, Brazil. Rev Panam Salud Publica. 2008;23(1):34–43.
   PubMed Web of Science ®Google Scholar
• Chan DC, Hao YT, Wu SC. Polypharmacy among disabled Taiwanese elderly: a longitudinal observational study. Drugs Aging. 2009;26(4):345–354.
   PubMed Web of Science ®Google Scholar
• Venturini CD, Engroff P, Ely LS, et al. Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics (Sao Paulo, Brazil). 2011;66(11):1867–1872.
   PubMed Web of Science ®Google Scholar
• Chrischilles EA, Foley DJ, Wallace RB, et al. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol. 1992;47(5):M137–M144.
   PubMedGoogle Scholar
• Republika Srpska Institute of Statistics. [Women and men in Republika Srpska. Bulletin No 6]. Žene i muškarci u Republici Srpskoj broj 6. 2012. Serbian.
   Google Scholar
• Jakovljevic MB. Targeted immunotherapies overtaking emerging oncology market value based growth. J BUON. 2015;20(1):350–351.
   PubMed Web of Science ®Google Scholar
• Dragovic A, Zugic A, Jakovljevic MB. Mlacroeconomic policy impact on oncology-related public expenditure in an emerging european market – signs of early recovery. Ser J Exp Clin Res. 2015;16(1):43–50.
   Google Scholar
• Jakovljevic MB, Jovanovic M, Lesch OM. Accessibility and affordability of alcohol dependency medical care in serbia. Front Psychiatry. 2014;5:192.
   PubMed Web of Science ®Google Scholar
• Republika Srpska Institute of Statistics. [Demographic statistics. Bulletin No 5]. Demografski bilten broj 5. 2002. Serbian.
   Google Scholar
• Jakovljevic M, Laaser U. Population aging from 1950 to 2010 in seventeen transitional countries in the wider region of South Eastern Europe. SEEJPH; 2015; Posted Feb 21. DOI:10.12908/SEEJPH-2014-42.
   Google Scholar
• Markovic-Pekovic V, Stoisavljevic-Satara S, Skrbic R. Utilisation of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study. Pharmacoepidemiol Drug Saf. 2009;18(4):320–326.
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Social Welfare of the Republic of Srpska. [Guidelines for Clinical Practice. Cardiovascular diseases: Hypertension/Atrial fibrilation/Myocardial infarction/Angina pectoris]. Bolesti sistema krvotoka: Akutni infarkt miokarda. Atrijalna fibrilacija. Angina pektoris i bol u grudima. Arterijska hipertenzija. 2004. Serbian.
   Google Scholar
• Ministry of Health and Social Welfare of the Republic of Srpska. [Guideline for Diabetes mellitus]. Nacionalni vodič za Diabetes Mellitus. 2004. Serbian.
   Google Scholar
• Ministry of Health and Social Welfare of the Republic of Srpska. [Guideline for Hyperlipoproteinemia]. Vodič lipoproteinemije. 2004. Serbian.
   Google Scholar
• Hovstadius B, Hovstadius K, Astrand B, et al. Increasing polypharmacy - an individual-based study of the Swedish population 2005–2008. BMC Clin Pharmacol. 2010;10:16.
   PubMedGoogle Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703–713.
   PubMed Web of Science ®Google Scholar
• Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643–2653.
   PubMed Web of Science ®Google Scholar
• SIGN. Management of diabetes. Available from: http://www.sign.ac.uk/pdf/qrg116.pdf.
   Google Scholar
• Lionakis N, Mendrinos D, Sanidas E, et al. Hypertension in the elderly. World J Cardiol. 2012;4(5):135–147.
   PubMedGoogle Scholar
• Dickerson LM, Gibson MV. Management of hypertension in older persons. Am Fam Physician. 2005;71(3):469–476.
   PubMed Web of Science ®Google Scholar
• Editorial. Digoxin: serious drug interactions. Prescrire Int. 2010;19(106):68–70.
   PubMedGoogle Scholar
• Ministry of Health and Social Welfare of the Republic of Srpska. [Guideline for Heart failure]. Vodič srčana insuficijencija. 2007. Serbian.
   Google Scholar
• NICE. Chronic heart failure. NICE clinical guideline 108. Available from: https://www.nice.org.uk/guidance/cg108/resources/guidance-chronic-heart-failure-pdf.
   Google Scholar
• Barnes PJ. Theophylline. Am J Respir Crit Care Med. 2013;188(8):901–906.
   PubMed Web of Science ®Google Scholar
• Berbecaru-Iovan S, Popescu F, Berbecaru-Iovan A. Considerations on the broncholdilator therapy in elderly patients with obstructive bronchial syndrome. Curr Health Sci J. 2013;39:197–203.
   Google Scholar
• Ribeiro AQ, Rozenfeld S, Klein CH, et al. [Survey on medicine use by elderly retirees in Belo Horizonte, Southeastern Brazil]. Rev Saude Publica. 2008;42(4):724–732.
   PubMed Web of Science ®Google Scholar
• Vukovic M, Gvozdenovic BS, Rankovic M, et al. Can didactic continuing education improve clinical decision making and reduce cost of quality? Evidence from a case study. J Contin Educ Health Prof. 2015;35(2):109–118.
   PubMed Web of Science ®Google Scholar
• Vezmar Kovacevic S, Simisic M, Stojkov Rudinski S, et al. Potentially inappropriate prescribing in older primary care patients. Plos One. 2014;9(4):e95536.
   PubMed Web of Science ®Google Scholar
• Stefanovic SM, Jankovic SM. Knowledge of the pharmacological profile of a patient improves the quality of prescribing, the outcomes of treatment, and the utilization of health services in primary health care. Eur J Clin Pharmacol. 2011;67(11):1091–1101.
   PubMed Web of Science ®Google Scholar